Yuka Suzuki

14PUBLICATIONS
14CO-AUTHORS
Haematological tumoursMolecular targetsTumour immunologyAutoimmunityCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Nov 25, 2020
Histiocytic and dendritic cell neoplasms: Reappraisal of a Japanese series based on t(14;18) and neoplastic PD-L1 expression.

Kanae Okada, Taishi Takahara, Yuka Suzuki

|May 20, 2020
PD-L1 expression on tumor or stromal cells of nodal cytotoxic T-cell lymphoma: A clinicopathological study of 50 cases.

Daisuke Yamashita, Kazuyuki Shimada, Kei Kohno

|May 06, 2020
PD-L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B-cell lymphoma treated with rituximab-based multi-agent chemotherapy.

Yuka Suzuki, Kei Kohno, Kosei Matsue

|May 06, 2020
Age-related EBV-associated B-cell lymphoproliferative disorders and other EBV + lymphoproliferative diseases: New insights into immune escape and immunodeficiency through staining with anti-PD-L1 antibody clone SP142.

Ayako Sakakibara, Kei Kohno, Eri Ishikawa

|Jan 03, 2020
Syncytial variant of classic Hodgkin lymphoma: Four cases diagnosed with the aid of CD274/programmed cell death ligand 1 immunohistochemistry.

Kei Kohno, Ayako Sakakibara, Akari Iwakoshi

|Jan 03, 2020
Diagnostic utility of programmed cell death ligand 1 (clone SP142) in mediastinal composite lymphoma: A report of two cases.

Ayako Sakakibara, Kei Kohno, Akari Iwakoshi

Pageof 3

Frequent Collaborators

10 joint publications

Akira Satou

4 joint publications

Kei Kohno

4 joint publications

Ayako Sakakibara

4 joint publications

Taishi Takahara